Literature DB >> 30216773

Long-term exposure to wind turbine noise and redemption of antihypertensive medication: A nationwide cohort study.

Aslak Harbo Poulsen1, Ole Raaschou-Nielsen2, Alfredo Peña3, Andrea N Hahmann3, Rikke Baastrup Nordsborg4, Matthias Ketzel5, Jørgen Brandt5, Mette Sørensen6.   

Abstract

Noise from wind turbines (WTs) has been reported more annoying than traffic noise at similar levels, and concerns have been raised about whether WT noise (WTN) can increase risk for cardiovascular disease. We aimed to investigate if long-term exposure to WTN increases risk for hypertension, estimated as redemption of prescriptions for antihypertensive drugs. We identified all Danish dwellings within a radius of 20 WT heights from a WT and 25% randomly selected dwellings within 20-40 WT heights radius. Using data on WT type and hourly wind conditions at each WT, we estimated hourly outdoor (10-10,000 Hz) and low frequency (LF: 10-160 Hz) indoor WTN for all dwellings, and aggregated it as long-term nighttime running means. From nationwide registries, we identified 535,675 persons age 25-85 years living in these dwellings for >1 year from 1996 to 2013, of whom 83,729 fulfilled our case definition of redeeming ≥2 prescriptions and ≥180 defined daily doses of antihypertensive drugs within a year. Data were analyzed using Poisson regression according to categories of WTN exposure and adjustment for individual and area-level covariates. We found no associations between 5-year mean exposure to WTN during night and redemption of antihypertensives, with hazard ratios (HR) of 0.91 (95% confidence intervals (CI): 0.78-1.06) for outdoor WTN ≥ 42 dB(A) and of 1.06 (CI: 0.83-1.35) for indoor LF WTN ≥ 15 dB(A) when compared to the reference WTN levels (<24 dB(A) and <5 dB(A), respectively). The lack of association was consistent across sub-populations of people living on farms, far from major roads and with high validity of the noise estimate. For people younger than 65 years we found HRs of 0.81 (95% CI: 0.67-0.98) and 0.94 (95% CI: 0.68-1.30) for outdoor WTN ≥ 42 dB(A) and indoor WTN ≥ 15 dB(A), respectively, whereas for people above 65 years the corresponding HRs were 1.17 (95% CI: 0.90-1.52) and 1.28 (95% CI: 0.87-1.88). In conclusion, the present study does not support an association between WTN and redemption of antihypertensive medication.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antihypertensives; Epidemiology; Hypertension; Prescription; Prospective; Wind turbine noise

Mesh:

Substances:

Year:  2018        PMID: 30216773     DOI: 10.1016/j.envint.2018.08.054

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  4 in total

1.  Road Traffic Noise Exposure and Filled Prescriptions for Antihypertensive Medication: A Danish Cohort Study.

Authors:  Jesse D Thacher; Aslak H Poulsen; Nina Roswall; Ulla Hvidtfeldt; Ole Raaschou-Nielsen; Steen Solvang Jensen; Matthias Ketzel; Jørgen Brandt; Kim Overvad; Anne Tjønneland; Thomas Münzel; Mette Sørensen
Journal:  Environ Health Perspect       Date:  2020-05-14       Impact factor: 9.031

Review 2.  Evidence Relating to Environmental Noise Exposure and Annoyance, Sleep Disturbance, Cardio-Vascular and Metabolic Health Outcomes in the Context of IGCB (N): A Scoping Review of New Evidence.

Authors:  Irene van Kamp; Sendrick Simon; Hilary Notley; Christos Baliatsas; Elise van Kempen
Journal:  Int J Environ Res Public Health       Date:  2020-04-26       Impact factor: 3.390

3.  A laboratory study on the effects of wind turbine noise on sleep: results of the polysomnographic WiTNES study.

Authors:  Michael G Smith; Mikael Ögren; Pontus Thorsson; Laith Hussain-Alkhateeb; Eja Pedersen; Jens Forssén; Julia Ageborg Morsing; Kerstin Persson Waye
Journal:  Sleep       Date:  2020-09-14       Impact factor: 5.849

4.  Assessing Potential Health Impacts of Wind Turbine Noise: A Longitudinal Look at Multiple End Points.

Authors:  Nate Seltenrich
Journal:  Environ Health Perspect       Date:  2019-09-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.